Statements 25 Sep 2026 DNDi intervention at the UN High-Level Meeting on Pandemic Prevention, Preparedness, and Response at the 81st UN General Assembly
In the media 24 Sep 2026 De Etiopía a Lleida: la desigualdad mata tanto como los virus durante una pandemia El País
News 15 Sep 2026 New DNDi report: Implementing Article 9.5 of the WHO Pandemic Agreement – building on current policy and practice for publicly funded R&D
In the media 9 Sep 2026 Des acteurs pharmaceutiques à but non lucratif s’allient pour faire face à la baisse des financements Swissinfo
Scientific articles 15 Aug 2026 Identification of new Trypanosoma cruzi-specific protein synthesis inhibitors by using a developed high-throughput in vitro translation assay International Journal for Parasitology: Drugs and Drug Resistance
Scientific articles 5 Aug 2026 ICH E21: from landmark guidance to specific action for maternal and child health
Scientific articles 3 Aug 2026 A Phase IIa, Proof-of-Concept, Placebo-Controlled, Randomised Trial to Investigate the Efficacy and Safety of Oxfendazole as a Macrofilaricidal Drug in Adults Harbouring Lymphatic Filarial Worms Infectious Diseases and Therapy
Press releases 23 Jul 2018 FIND and DNDi team up to support Malaysian MOH efforts to simplify and decentralize hepatitis C screening & treatment
Press releases 14 Apr 2018 DNDi agreement with Colombia Ministry of Health and Social Welfare to guarantee access to comprehensive care for Chagas patients
Press releases 13 Apr 2018 Clinical trial to find new treatment for visceral leishmaniasis begins in eastern Africa
Press releases 5 Apr 2018 Takeda Pharmaceutical and DNDi collaborate to progress a potential new drug for visceral leishmaniasis through the R&D pipeline
Press releases 27 Mar 2018 DNDi, GlaxoSmithKline, and University of Dundee to identify drug candidates to treat leishmaniasis and Chagas disease
Press releases 5 Mar 2018 Pharmaceutical companies and non-profits team up to provide affordable hepatitis C treatment in Latin America
Press releases 31 Jan 2018 Sanofi, DNDi seek European Medicines Agency review for sleeping sickness treatment
Press releases 13 Nov 2017 Pharmaniaga, Pharco and DNDi sign agreement to provide affordable hepatitis C treatment in Malaysia
Press releases 8 Nov 2017 DNDi/GARDP opens new South Africa liaison office, hosted by South African Medical Research Council
Press releases 4 Nov 2017 Phase II/III studies show high efficacy and safety of fexinidazole, the first oral treatment for sleeping sickness
Press releases 20 Sep 2017 DNDi welcomes Malaysia’s move to secure access to more affordable treatments for hepatitis C
Press releases 4 Sep 2017 More than EUR 56 million raised to fund initiative to fight antibiotic resistance
Press releases 31 Aug 2017 U.S. FDA approves Chemo Group’s benznidazole to treat children with Chagas disease
